Partner in smart MDx assay development

Multiplex qPCR - Point of Care Applications - Antibiotic Resistance Detection

NYtor designs and develops molecular detection assays in the field of human and veterinary infectious disease diagnostics. Our main focus is the development of smart molecular assays for the detection of antibiotic resistance.

NYtor works with innovative technologies to enable development of ultra-sensitive and highly specific molecular diagnostics assays.

Technology:
  • Microbial diagnostics

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental

Development stage:
  • Research
  • Development

Organization:
  • Company

Partnering:
  • Co-develop

With co-developing partners that perform final validation, CE-registration, production and sales

NYtor employs an enthusiastic and motivated team of PhDs and technicians with ample experience and state-of-the-art knowledge of MDx assay development

Assays available for commercialization:
STIs:
• NG + quinolone resistance
• MG + macrolide and quinolone resistance

CPE/ESBL:
• CPE : KPC, OXA48 (including OXA181), VIM and NDM (+IMP)
• ESBL : CTX-M-1; CTX-M-2; CTX-M-9 groups and SHV-ESBL


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!